Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark

NCT05452798 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05452798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05452798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
February 1, 2022
Completion date
August 1, 2022
Enrollment
1,054 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer